211 related articles for article (PubMed ID: 2442558)
1. Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure.
Dickstein K
J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S73-81. PubMed ID: 2442558
[TBL] [Abstract][Full Text] [Related]
2. Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure.
Dickstein K; Aarsland T; Woie L; Abrahamsen AM; Fyhrquist F; Cummings S; Gomex HJ; Hagen E; Kristianson K
Am Heart J; 1986 Jul; 112(1):121-9. PubMed ID: 3014850
[TBL] [Abstract][Full Text] [Related]
3. Acute hemodynamic and hormonal effects of MK-521 in congestive heart failure.
Dickstein K; Aarsland T; Woie L; Kremer D; Abrahamsen AM
Scand J Urol Nephrol Suppl; 1984; 79():125-7. PubMed ID: 6089311
[TBL] [Abstract][Full Text] [Related]
4. Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes.
Woie L; Dickstein K; Kaada B
Gen Pharmacol; 1987; 18(6):577-87. PubMed ID: 2822521
[TBL] [Abstract][Full Text] [Related]
5. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
Mitrovic V; Mudra H; Bonzel T; Schmidt W; Schlepper M
Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure.
Mitrovic V; Mudra H; Bonzel T; Schmidt W; Strand JC; Bakovic-Alt R; Posvar EL
Clin Pharmacol Ther; 1996 Jun; 59(6):686-98. PubMed ID: 8681494
[TBL] [Abstract][Full Text] [Related]
7. Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses.
Uretsky BF; Shaver JA; Liang CS; Amin D; Shah PK; Levine TB; Walinsky P; LeJemtel T; Linnemeier T; Rush JE
Am Heart J; 1988 Aug; 116(2 Pt 1):480-8. PubMed ID: 2840815
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of lisinopril after long-term administration in congestive heart failure.
Stone CK; Uretsky BF; Linnemeier TJ; Shah PK; Amin DK; Snapinn SM; Rush JE; Langendörfer A; Liang CS
Am J Cardiol; 1989 Mar; 63(9):567-70. PubMed ID: 2537566
[TBL] [Abstract][Full Text] [Related]
9. The acute hemodynamic, hormonal, and pharmacokinetic properties of oral spirapril in patients with moderate to severe heart failure.
van den Broek SA; van Bruggen A; de Graeff PA; Hillege H; van Gilst WH; Wesseling H; Lie KI
J Cardiovasc Pharmacol; 1991 Oct; 18(4):614-21. PubMed ID: 1724540
[TBL] [Abstract][Full Text] [Related]
10. A comparison of lisinopril with enalapril by monitoring plasma angiotensin II levels in humans.
Kawamura M; Imanishi M; Matsushima Y; Akabane S; Kuramochi M; Ito K; Omae T
Jpn J Pharmacol; 1990 Oct; 54(2):143-9. PubMed ID: 1963909
[TBL] [Abstract][Full Text] [Related]
11. Lisinopril in hypertensive patients with and without renal failure.
van Schaik BA; Geyskes GG; Boer P
Eur J Clin Pharmacol; 1987; 32(1):11-6. PubMed ID: 3034622
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive and hormonal effects of lisinopril, a new angiotensin converting enzyme (ACE) inhibitor in patients with renovascular hypertension.
Karlberg BE; Rosenqvist U
Acta Med Scand Suppl; 1986; 714():33-42. PubMed ID: 3033998
[TBL] [Abstract][Full Text] [Related]
13. Acute Hemodynamic and Hormonal Effects of Mk-521 in Congestive Heart Failure.
Dickstein K; Aarsland T; Woie L; Kremer D; Abrahamsen AM
Scand J Urol Nephrol; 1984 Jul; 18(sup79):125-127. PubMed ID: 27785997
[TBL] [Abstract][Full Text] [Related]
14. How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
MacFadyen RJ; Lee AF; Morton JJ; Pringle SD; Struthers AD
Heart; 1999 Jul; 82(1):57-61. PubMed ID: 10377310
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics of lisinopril in hospitalized patients with congestive heart failure.
Till AE; Dickstein K; Aarsland T; Gomez HJ; Gregg H; Hichens M
Br J Clin Pharmacol; 1989 Feb; 27(2):199-204. PubMed ID: 2540786
[TBL] [Abstract][Full Text] [Related]
16. Systemic, pulmonary, brachial, renal and hepato-splanchnic hemodynamic effects of spirapril in severe congestive heart failure.
Bellissant E; Annane D; Pussard E; Thuillez C; Giudicelli JF
Fundam Clin Pharmacol; 1996; 10(2):127-35. PubMed ID: 8737955
[TBL] [Abstract][Full Text] [Related]
17. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
Sigurdsson A
Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
[TBL] [Abstract][Full Text] [Related]
18. Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure.
De Marco T; Daly PA; Liu M; Kayser S; Parmley WW; Chatterjee K
J Am Coll Cardiol; 1987 May; 9(5):1131-8. PubMed ID: 3033043
[TBL] [Abstract][Full Text] [Related]
19. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
Reams GP; Lal SM; Whalen JJ; Bauer JH
J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors: a comparative review.
Raia JJ; Barone JA; Byerly WG; Lacy CR
DICP; 1990 May; 24(5):506-25. PubMed ID: 2188439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
